Page 30 - மூலக்கூறு ஆய்வகம் அலகு ஆஃப் தி ஆய்வகம் சேவைகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மூலக்கூறு ஆய்வகம் அலகு ஆஃப் தி ஆய்வகம் சேவைகள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மூலக்கூறு ஆய்வகம் அலகு ஆஃப் தி ஆய்வகம் சேவைகள் Today - Breaking & Trending Today

Viewpoint Molecular Targeting, Inc.: Viewpoint Molecular Targeting Announces Closing of Its Series A Financing with Proceeds of $13 Million


Viewpoint Molecular Targeting, Inc.: Viewpoint Molecular Targeting Announces Closing of Its Series A Financing with Proceeds of $13 Million
??
-NET into Phase 1 imaging studies beginning in 2021 and accelerate development of radioisotope production technologies
CORALVILLE, IA / ACCESSWIRE / January 8, 2021 / Viewpoint Molecular Targeting, Inc. ( Viewpoint or the Company ), a radiopharmaceutical company developing precision α-particle oncology
therapeutics and complementary diagnostic imaging agents, announced today it has closed the third and final tranche of its Series A financing for a total of approximately $13 million. Proceeds from the financing will be used to advance the Company s two lead programs, VMT01 and VMT-??-NET, into Phase 1 human clinical studies, further develop its proprietary VMT-??-GEN isotope generator, and fund general operating expenses. ....

Jenene Thomas , Kostenloser Wertpapierhandel , Michaelk Schultz , Frances Johnson , University Of Iowa , Viewpoint Molecular Targeting Inc , University Of Iowa Bioventures Center , Viewpoint Molecular Targeting , Chief Medical Officer , Chief Science Officer , Iowa Bioventures Center , Molecular Targeting , பிரான்சிஸ் ஜான்சன் , பல்கலைக்கழகம் ஆஃப் ஐயுவா , தலைமை மருத்துவ அதிகாரி , தலைமை அறிவியல் அதிகாரி ,

First steps toward uncovering CRISPR/Cas gene doping in plasma


First steps toward uncovering CRISPR/Cas gene doping in plasma
All athletes want to be at the top of their game when they compete, but some resort to nefarious approaches to achieve peak muscle growth, speed and agility. Recent developments in gene editing technology could tempt athletes to change their DNA to get an edge. Now, researchers reporting in ACS
Analytical Chemistry demonstrate first steps toward detecting this type of doping both in human plasma and in live mice.
The gene editing method called CRISPR/Cas is a popular way for scientists to precisely change the DNA in many organisms, and it recently gained even more attention when key developers of the method were awarded the 2020 Nobel Prize in Chemistry. With this method, researchers add an RNA molecule and a protein into cells. The RNA molecule guides the protein to the appropriate DNA sequence, and then the protein cuts DNA, like a pair of scissors, to allow alterations. ....

Mario Thevis , Emily Henderson , Analytical Chemistry , World Anti Doping Agency , எமிலி ஹென்டர்சன் , பகுப்பாய்வு வேதியியல் ,

Non-toxic versions of botulism toxins can deliver therapeutic antibodies to treat botulism


Non-toxic versions of botulism toxins can deliver therapeutic antibodies to treat botulism
Taking advantage of the chemical properties of botulism toxins, two teams of researchers have fashioned non-toxic versions of these compounds that can deliver therapeutic antibodies to treat botulism, a potentially fatal disease with few approved treatments.
The research, which was conducted in mice, guinea pigs, and nonhuman primates, suggests that the toxin derivatives could one day offer a platform to quickly treat established cases of botulism and target hard-to-reach molecules within neurons. Botulism manifests due to bacterial toxins called botulinum neurotoxins (BoNTs), which are the most potent toxins known to humans. ....

Shin Ichiro Miyashita , Patrick Mcnutt , Emily Henderson , பேட்ரிக் ம்க்ணுத்த் , எமிலி ஹென்டர்சன் ,

Scientist receives $1.37 million grant to advance metabolomics data


Scientist receives $1.37 million grant to advance metabolomics data
The National Institutes of Health (NIH) has awarded University of Massachusetts Amherst biostatistician Raji Balasubramanian a four-year, $1.37 million grant to advance the analysis of data from metabolomics research. These studies examine at the molecular level the links between metabolic action and the risk of chronic health conditions, from heart disease and stroke to breast cancer and other complex disorders.
Balasubramanian, associate professor of biostatistics and epidemiology in the School of Public Health and Health Sciences, will co-lead an interdisciplinary team in the development and application of new statistical models to more effectively mine the expanding base of metabolomics data sources. The other lead investigator is Denise Scholtens, chief of biostatistics and director of the Northwestern University Data Analysis and Coordinating Center. ....

Denise Scholtens , Raji Balasubramanian , Emily Henderson , Northwestern University Data Analysis , University Of Massachusetts Amherst , National Institutes Of Health , Harvard Medical School , School Of Public Health , Health Sciences , National Institutes , Massachusetts Amherst , Public Health , Associate Professor , Breast Cancer , Heart Disease , மறுக்க ஸ்கோல்டென்ஸ் , ராஜி பாலசுப்ரமணியன் , எமிலி ஹென்டர்சன் , வடமேற்கு பல்கலைக்கழகம் தகவல்கள் பகுப்பாய்வு , பல்கலைக்கழகம் ஆஃப் மாசசூசெட்ஸ் மஹேர்ஸ்ட , தேசிய நிறுவனங்கள் ஆஃப் ஆரோக்கியம் , ஹார்வர்ட் மருத்துவ பள்ளி , பள்ளி ஆஃப் பொது ஆரோக்கியம் , ஆரோக்கியம் அறிவியல் , தேசிய நிறுவனங்கள் , மாசசூசெட்ஸ் மஹேர்ஸ்ட ,